CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −11,950 | $62.16 | $743K | 31,926 |
| 2025-09-09 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −11,950 | 41,700 | ||
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +20,000 | $60.89 | $1.2M | 77,130 |
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −20,000 | $64.56 | $1.3M | 57,130 |
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +1,000 | $56.78 | $57K | 58,130 |
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −1,000 | $64.56 | $65K | 57,130 |
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,000 | 57,203 | ||
| 2025-09-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −20,000 | 34,461 | ||
| 2025-09-05 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +250 | $31.80 | $8K | 32,176 |
| 2025-09-05 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −250 | $62.00 | $16K | 31,926 |
| 2025-09-05 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −250 | 53,650 | ||
| 2025-09-05 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −6,000 | $59.60 | $358K | 82,679 |
| 2025-09-03 | WENDER JOSEPH H Director | Sale 10b5-1 | −11,200 | $60.14 | $674K | 108,835 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Option exercise | +102,900 | $53.77 | $5.5M | 282,909 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Sale | −16,615 | $59.12 | $982K | 266,294 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Option exercise | +42,030 | $37.58 | $1.6M | 308,324 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Sale | −127,500 | $60.13 | $7.7M | 180,824 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Option exercise | +31,316 | $32.60 | $1.0M | 212,140 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Option exercise | +27,568 | $32.60 | $899K | 239,708 |
| 2025-09-03 | Monia Brett P Chief Executive Officer | Sale | −59,699 | $61.06 | $3.6M | 180,009 |
Page 24 of 34 · 668 trades